Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
5.73
+0.45 (8.52%)
At close: May 12, 2025, 4:00 PM
5.61
-0.12 (-2.09%)
After-hours: May 12, 2025, 5:37 PM EDT
Quanterix Employees
Quanterix had 471 employees as of December 31, 2024. The number of employees increased by 30 or 6.80% compared to the previous year.
Employees
471
Change (1Y)
30
Growth (1Y)
6.80%
Revenue / Employee
$288,085
Profits / Employee
-$101,639
Market Cap
222.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
QTRX News
- 4 hours ago - Quanterix Releases Financial Results for the First Quarter of 2025 - Business Wire
- 5 days ago - AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA - Business Wire
- 7 days ago - Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025 - Business Wire
- 12 days ago - Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders - Business Wire
- 13 days ago - Quanterix and Akoya Biosciences Announce Amended Merger Agreement - Business Wire
- 25 days ago - Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders - Business Wire
- 4 weeks ago - Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences - Business Wire
- 5 weeks ago - Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya - Business Wire